These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21997225)

  • 1. Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.
    Compston J
    Osteoporos Int; 2011 Dec; 22(12):2951-61. PubMed ID: 21997225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on Compston: pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.
    Michaëlsson K; Schilcher J; Aspenberg P
    Osteoporos Int; 2012 Dec; 23(12):2901-2. PubMed ID: 22290240
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteonecrosis and atypical fractures-common origins?
    Subramanian G; Fritton JC; Quek SY
    Osteoporos Int; 2013 Feb; 24(2):745-6. PubMed ID: 22407260
    [No Abstract]   [Full Text] [Related]  

  • 4. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and pathogenesis of osteonecrosis of the jaw.
    Reid IR; Cornish J
    Nat Rev Rheumatol; 2011 Nov; 8(2):90-6. PubMed ID: 22124271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
    Fusco V; Galassi C; Berruti A; Ciuffreda L; Ortega C; Ciccone G; Angeli A; Bertetto O
    J Clin Oncol; 2011 Jun; 29(17):e521-2; author reply e523-4. PubMed ID: 21537047
    [No Abstract]   [Full Text] [Related]  

  • 8. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR; Burr DB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaw.
    Drozdzowska B
    Endokrynol Pol; 2011; 62(1):88-92. PubMed ID: 21365586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between osteonecrosis of the jaw and bisphosphonate treatment].
    Badel T; Keros J; Krapac L; Pavicin IS
    Arh Hig Rada Toksikol; 2010 Sep; 61(3):371-80. PubMed ID: 20860977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines.
    Pickett FA;
    J Dent Hyg; 2006; 80(3):10. PubMed ID: 16953991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New oncology drugs and osteonecrosis of the jaw (ONJ).
    Migliorati CA; Covington JS
    J Tenn Dent Assoc; 2009; 89(4):36-8; quiz 38-9. PubMed ID: 20102031
    [No Abstract]   [Full Text] [Related]  

  • 13. More about osteonecrosis.
    Finkelman RD; Clemons M; Bouganim N
    J Am Dent Assoc; 2011 Apr; 142(4):371-2; author reply 372-4. PubMed ID: 21454842
    [No Abstract]   [Full Text] [Related]  

  • 14. A current update on osteonecrosis of the jaw and bisphosphonates.
    Arrain Y; Masud T
    Dent Update; 2011 Dec; 38(10):672-6, 678. PubMed ID: 22408887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates and atypical femoral fractures.
    Hofbauer LC; Jakob F; Felsenberg D
    N Engl J Med; 2010 Sep; 363(11):1084; author reply 1084-5. PubMed ID: 20848679
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential pathophysiological mechanisms in osteonecrosis of the jaw.
    Landesberg R; Woo V; Cremers S; Cozin M; Marolt D; Vunjak-Novakovic G; Kousteni S; Raghavan S
    Ann N Y Acad Sci; 2011 Feb; 1218():62-79. PubMed ID: 21291478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
    Naik NH; Russo TA
    Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaw and the role of macrophages.
    Pazianas M
    J Natl Cancer Inst; 2011 Feb; 103(3):232-40. PubMed ID: 21189409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.